Deficiency of the innate immune adaptor STING promotes autoreactive T cell expansion in NOD mice
- PMID: 33483762
- DOI: 10.1007/s00125-020-05378-z
Deficiency of the innate immune adaptor STING promotes autoreactive T cell expansion in NOD mice
Abstract
Aims/hypothesis: Stimulator of IFN genes (STING) is a central hub for cytosolic nucleic acid sensing and its activation results in upregulation of type I IFN production in innate immune cells. A type I IFN gene signature seen before the onset of type 1 diabetes has been suggested as a driver of disease initiation both in humans and in the NOD mouse model. A possible source of type I IFN is through activation of the STING pathway. Recent studies suggest that STING also has antiproliferative and proapoptotic functions in T cells that are independent of IFN. To investigate whether STING is involved in autoimmune diabetes, we examined the impact of genetic deletion of STING in NOD mice.
Methods: CRISPR/Cas9 gene editing was used to generate STING-deficient NOD mice. Quantitative real-time PCR was used to assess the level of type I IFN-regulated genes in islets from wild-type and STING-deficient NOD mice. The number of islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP)206-214-specific CD8+ T cells was determined by magnetic bead-based MHC tetramer enrichment and flow cytometry. The incidence of spontaneous diabetes and diabetes after adoptive transfer of T cells was determined.
Results: STING deficiency partially attenuated the type I IFN gene signature in islets but did not suppress insulitis. STING-deficient NOD mice accumulated an increased number of IGRP206-214-specific CD8+ T cells (2878 ± 642 cells in NOD.STING-/- mice and 728.8 ± 196 cells in wild-type NOD mice) in peripheral lymphoid tissue, associated with a higher incidence of spontaneous diabetes (95.5% in NOD.STING-/- mice and 86.2% in wild-type NOD mice). Splenocytes from STING-deficient mice rapidly induced diabetes after adoptive transfer into irradiated NOD recipients (median survival 75 days for NOD recipients of NOD.STING-/- mouse splenocytes and 121 days for NOD recipients of NOD mouse splenocytes).
Conclusions/interpretation: Data suggest that sensing of endogenous nucleic acids through the STING pathway may be partially responsible for the type I IFN gene signature but not autoimmunity in NOD mice. Our results show that the STING pathway may play an unexpected intrinsic role in suppressing the number of diabetogenic T cells.
Keywords: CD8+ T cells; NOD mice; STING; Type 1 diabetes; Type 1 interferon.
Similar articles
-
Lung Inflammation in STING-Associated Vasculopathy with Onset in Infancy (SAVI).Cells. 2022 Jan 18;11(3):318. doi: 10.3390/cells11030318. Cells. 2022. PMID: 35159128 Free PMC article. Review.
-
Reduced Function of the Adaptor SH2B3 Promotes T1D via Altered Cytokine-Regulated, T-Cell-Intrinsic Immune Tolerance.Diabetes. 2025 Jun 1;74(6):943-955. doi: 10.2337/db24-0655. Diabetes. 2025. PMID: 40048557
-
Deletion of the G6pc2 gene encoding the islet-specific glucose-6-phosphatase catalytic subunit-related protein does not affect the progression or incidence of type 1 diabetes in NOD/ShiLtJ mice.Diabetes. 2011 Nov;60(11):2922-7. doi: 10.2337/db11-0220. Epub 2011 Sep 6. Diabetes. 2011. PMID: 21896930 Free PMC article.
-
BAFF regulates activation of self-reactive T cells through B-cell dependent mechanisms and mediates protection in NOD mice.Eur J Immunol. 2014 Apr;44(4):983-93. doi: 10.1002/eji.201344186. Epub 2014 Feb 16. Eur J Immunol. 2014. PMID: 24435807
-
NOD mice and autoimmunity.Autoimmun Rev. 2005 Jul;4(6):373-9. doi: 10.1016/j.autrev.2005.02.002. Epub 2005 Mar 29. Autoimmun Rev. 2005. PMID: 16081028 Review.
Cited by
-
The Function of cGAS-STING Pathway in Treatment of Pancreatic Cancer.Front Immunol. 2021 Nov 9;12:781032. doi: 10.3389/fimmu.2021.781032. eCollection 2021. Front Immunol. 2021. PMID: 34858438 Free PMC article. Review.
-
The cGAS-STING pathway: a therapeutic target in diabetes and its complications.Burns Trauma. 2024 Feb 2;12:tkad050. doi: 10.1093/burnst/tkad050. eCollection 2024. Burns Trauma. 2024. PMID: 38312740 Free PMC article. Review.
-
Applications of Genome-Editing Technologies for Type 1 Diabetes.Int J Mol Sci. 2023 Dec 26;25(1):344. doi: 10.3390/ijms25010344. Int J Mol Sci. 2023. PMID: 38203514 Free PMC article. Review.
-
Autoimmune CD8+ T cells in type 1 diabetes: from single-cell RNA sequencing to T-cell receptor redirection.Front Endocrinol (Lausanne). 2024 May 10;15:1377322. doi: 10.3389/fendo.2024.1377322. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38800484 Free PMC article. Review.
-
Lung Inflammation in STING-Associated Vasculopathy with Onset in Infancy (SAVI).Cells. 2022 Jan 18;11(3):318. doi: 10.3390/cells11030318. Cells. 2022. PMID: 35159128 Free PMC article. Review.
References
-
- Craig ME, Kim KW, Isaacs SR et al (2019) Early-life factors contributing to type 1 diabetes. Diabetologia 62(10):1823–1834. https://doi.org/10.1007/s00125-019-4942-x - DOI - PubMed
-
- Rewers M, Ludvigsson J (2016) Environmental risk factors for type 1 diabetes. Lancet 387(10035):2340–2348. https://doi.org/10.1016/S0140-6736(16)30507-4 - DOI - PubMed - PMC
-
- van der Werf N, Kroese FG, Rozing J, Hillebrands JL (2007) Viral infections as potential triggers of type 1 diabetes. Diabetes Metab Res Rev 23(3):169–183. https://doi.org/10.1002/dmrr.695 - DOI - PubMed
-
- Pane JA, Coulson BS (2015) Lessons from the mouse: potential contribution of bystander lymphocyte activation by viruses to human type 1 diabetes. Diabetologia 58(6):1149–1159. https://doi.org/10.1007/s00125-015-3562-3 - DOI - PubMed
-
- Ablasser A, Chen ZJ (2019) cGAS in action: Expanding roles in immunity and inflammation. Science 363(6431):eaat8657. https://doi.org/10.1126/science.aat8657 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials